Drug Substance Manufacturing - Mammalian Cell Cultures

Drug Substance Manufacturing - Mammalian Cell Cultures

Products
Drug Substance Manufacturing - Mammalian Cell Cultures
Drug Substance Manufacturing - Mammalian Cell Cultures

Information

Around 430,000 L total commercial capacity for cell culture Manufacturing sites around the globe: Biberach/Germany, Vienna/Austria, Fremont, CA/USA and Shanghai/ China- from 2,000 up to 15,000 L bioreactors GMP facilities licensed by EMA, FDA, MHLW and other authorities All analytic capabilities inhouse GMP batch release testing Manufacturing of mAbs, recombinant enzymes, Fab fragments, Fc fusion proteins, TandAb, Ig DART, and further complex biologics like bi- or multispecific mAbs
All Categories
Contract ManufacturingBiomanufacturing
Main Categories
Biopharmaceutical ProductsContract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)
Distribution Areas
North America (USA, Canada)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)
Boehringer Ingelheim Biopharmaceuticals GmbHBoehringer Ingelheim BioXcellence(TM) is the contract manufacturing arm of Boehringer Ingelheim and we have built a reputation as a reliable, world-class partner for biopharmaceuticals development and manufacturing. With facilities located in the USA, Europe, and Asia, we specialize in mammalian and microbial contract manufacturing, leveraging over 40 years of biotechnology expertise. We offer the full spectrum of services for late-stage products - with a hard-won reputation as a reliable partner accompanying you throughout the lifecycle of your product. Our trac...

Log in

See all the content and easy-to-use features by logging in or registering!